[Morganella morganii and early-onset neonatal infection].
Morganella morganii is an opportunistic gram-negative bacterium, resistant to ampicillin, and scarcely involved in early-onset neonatal sepsis.


METHODS
After a premature rupture of the membranes, a pregnant patient received prophylactic amoxicillin per os. She developed chorioamnionitis. Her infant was diagnosed with early-onset sepsis. Maternal and baby's blood cultures grew M. morganii. Both the mother and the infant were successfully treated with a third-generation cephalosporin and an aminoglycoside.


CONCLUSIONS
The influence of a prior antibiotherapy on the emergence of M. morganii vertical infections is discussed.
Boussemart
T
T
Service de pédiatrie B, CHRU de Pointe-à-Pitre, 97159 Pointe-à-Pitre, Guadeloupe. thierry.boussemart@wanadoo.fr
Piet-Duroux
S
S
Manouana
M
M
Azi
M
M
Perez
J M
JM
Port-Lis
M
M
D000284:Administration, Oral; D000328:Adult; D000617:Aminoglycosides / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D002511:Cephalosporins / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000150:complications*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000635:transmission; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D020613:Morganella morganii / Q000472:pathogenicity*; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D018805:Sepsis / Q000209:etiology
D000617:Aminoglycosides; D002511:Cephalosporins; D010406:Penicillins; D000658:Amoxicillin